#LET003
Harbour BioMed's Revolutionary AI-Driven Drug LET003 for Obesity Treatment Accepted by NMPA#China#Shanghai#Harbour_BioMed#AI_Drug#LET003
Harbour BioMed's Revolutionary AI-Driven Drug LET003 for Obesity Treatment Accepted by NMPA
Harbour BioMed announces the acceptance of its IND application for LET003, an AI-driven drug aimed at combatting obesity, offering a new path for treatment.
third-news.com
November 19, 2026 at 12:13 AM